Indian Companies Launch Weight Loss Drug Generics

Indian pharmaceutical companies have launched a wave of semaglutide-based weight loss alternatives after the patent expiration. This has made the popular drug more accessible to a wider audience. The new generics are quickly gaining market share due to their proven effectiveness. Analysts predict this will lead to lower prices for consumers globally. Increased competition is expected to drive further innovation in the obesity treatment sector.

Latest news

See all news

2026-03-28T10:30:30+00:00

Scientists Develop Gel for Needle-Free Insulin Delivery

Scientists have successfully tested a gel that efficiently delivers insulin to animals, normalizing blood sugar levels. This method could be an alternative to injections for patients who fear needles.

Health Country

2026-03-23T00:38:45+00:00

India at the Center of Ozempic Generic Price War

After the Ozempic patent expired, India has become a key market for generics. Over 40 manufacturers are preparing to launch more than 50 different versions of the drug, leading to fierce price competition.

Economy Health Country

2026-03-15T19:10:46+00:00

India Faces Energy Crisis due to Hormuz Strait Blockade

India, the world's second-largest LPG importer, is facing an unprecedented crisis due to the Hormuz Strait blockade. The government has imposed rationing and 'wartime economy' measures to supply 333 million households, impacting the hospitality sector and fueling a black market.

Economy Politics Health Country

2026-03-12T20:13:12+00:00

Woman in India Brings Herself Back to Life Thanks to a Pothole

In the Indian state of Uttar Pradesh, a woman declared brain-dead was saved by a pothole. While being transferred to another hospital, the ambulance hitting a pothole led to an instant restoration of her breathing, allowing her to return to life after two weeks of intensive therapy.

Health Events Country